Literature DB >> 25248729

A new anthracycline from endophytic Streptomyces sp. YIM66403.

Wei Li1, Xueqiong Yang1, Yabin Yang1, Lixing Zhao2, Lihua Xu2, Zhongtao Ding1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25248729     DOI： 10.1038/ja.2014.128

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  10 in total

1.  A new anthracycline antibiotic, cinerubin R. Taxonomy, structural elucidation and biological activity.

Authors:  M Nakata; M Saito; Y Inouye; S Nakamura; Y Hayakawa; H Seto
Journal:  J Antibiot (Tokyo)       Date:  1992-10       Impact factor: 2.649

2.  Aranciamycin anhydride, a new anthracycline-type antibiotic isolated from Streptomyces sp. Tü 6384(*).

Authors:  Jonny Nachtigall; Dirk Schulz; Winfried Beil; Roderich D Süssmuth; Hans-Peter Fiedler
Journal:  J Antibiot (Tokyo)       Date:  2010-06-16       Impact factor: 2.649

3.  The structure of a new anthracycline, cinerubin X produced by a blocked mutant of Streptomyces violaceochromogenes.

Authors:  M Nakagawa; K Furihata; K Furihata; K Adachi; H Seto; N Otake
Journal:  J Antibiot (Tokyo)       Date:  1986-08       Impact factor: 2.649

4.  [Studies on new anthracycline antibodies 80334 B, C and F. II. Fermentation, isolation, physicochemical properties, biological characteristics and structural determination].

Authors:  B Q Zhu; Y W Zhang; C N Zhang; C Tong
Journal:  Yao Xue Xue Bao       Date:  1986-06

Review 5.  Anthracyclines.

Authors:  Z Vanĕk; J Tax; I Komersová; P Sedmera; J Vokoun
Journal:  Folia Microbiol (Praha)       Date:  1977       Impact factor: 2.099

6.  Human tumor cells killed by anthracyclines induce a tumor-specific immune response.

Authors:  Jitka Fucikova; Petra Kralikova; Anna Fialova; Tomas Brtnicky; Lukas Rob; Jirina Bartunkova; Radek Spísek
Journal:  Cancer Res       Date:  2011-05-20       Impact factor: 12.701

7.  Synthetic studies on eta-pyrromycinone. V. Total synthesis of eta-pyrromycinone.

Authors:  Z Horii; T Momose; Y Tamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1965-07       Impact factor: 1.645

Review 8.  Role of apoptosis and apoptosis-related genes in cellular response and antitumor efficacy of anthracyclines.

Authors:  P Perego; E Corna; M De Cesare; L Gatti; D Polizzi; G Pratesi; R Supino; F Zunino
Journal:  Curr Med Chem       Date:  2001-01       Impact factor: 4.530

9.  Secondary metabolites from endophytic Streptomyces sp. Lz531.

Authors:  Pei-Ji Zhao; Hao-Xin Wang; Guo-Hong Li; Hua-Dong Li; Jin Liu; Yue-Mao Shen
Journal:  Chem Biodivers       Date:  2007-05       Impact factor: 2.408

10.  Antitumor agents from bohemic acid complex, III. The isolation of marcellomycin, musettamycin, rudolphomycin, mimimycin, collinemycin, alcindoromycin, and bohemamine.

Authors:  D E Nettleton; D M Balitz; T W Doyle; W T Bradner; D L Johnson; F A O'Herron; R H Schreiber; A B Coon; J E Moseley; R W Myllymaki
Journal:  J Nat Prod       Date:  1980 Mar-Apr       Impact factor: 4.050
  10 in total
  4 in total

1.  A new anthracycline-type metabolite from Streptomyces sp. NEAU-L3.

Authors:  Chang Lu; Yue Zhao; Wei-Qi Jia; Hui Zhang; Huan Qi; Wen-Sheng Xiang; Ji-Dong Wang; Xiang-Jing Wang
Journal:  J Antibiot (Tokyo)       Date:  2017-08-16       Impact factor: 2.649

Review 2.  Endophytic bacteria: a new source of bioactive compounds.

Authors:  Monika Singh; Ajay Kumar; Ritu Singh; Kapil Deo Pandey
Journal:  3 Biotech       Date:  2017-09-14       Impact factor: 2.406

Review 3.  Natural Products from Actinobacteria as a Potential Source of New Therapies Against Colorectal Cancer: A Review.

Authors:  Yadollah Bahrami; Sasan Bouk; Elham Kakaei; Mohammad Taheri
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

4.  Actinobacteria from Antarctica as a source for anticancer discovery.

Authors:  Leonardo Jose Silva; Eduardo José Crevelin; Danilo Tosta Souza; Gileno Vieira Lacerda-Júnior; Valeria Maia de Oliveira; Ana Lucia Tasca Gois Ruiz; Luiz Henrique Rosa; Luiz Alberto Beraldo Moraes; Itamar Soares Melo
Journal:  Sci Rep       Date:  2020-08-17       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.